The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?

Yan TereshkoMariarosaria ValenteEnrico BelgradoChiara Dalla TorreSimone Dal Bello Giovanni MerlinoGian Luigi GigliChristian Lettieri

Published in: Toxins (2023)

Botulinum toxin type A effectively reduced the pain, paroxysm frequency, and PFPS scores of type 1 and type 2 trigeminal neuralgia patients without statistically significant differences. Facial asymmetry was the only adverse event.

Keyphrases

botulinum toxin
neuropathic pain
end stage renal disease
emergency department
chronic kidney disease
newly diagnosed
spinal cord
pain management
peritoneal dialysis
prognostic factors